The global Endoscopic Submucosal Dissection (ESD) market is poised for substantial growth in the coming years, driven by a rising global incidence of gastrointestinal diseases, increasing focus on early gastrointestinal cancer detection, and the expanding adoption of minimally invasive surgery techniques. As awareness and access to advanced endoscopic techniques grow, healthcare systems worldwide are rapidly embracing therapeutic endoscopy procedures, fueling demand for ESD systems, tools, and clinical expertise.
Estimated at USD 388.38 million in 2025 , the global ESD market is expected to reach USD 618.18 million by 2034, expanding at a compound annual growth rate (CAGR) of 5.3%. ESD is a sophisticated endoscopic technique primarily used for en bloc resection of superficial tumors in the gastrointestinal tract, particularly within the esophagus, stomach, and colon.
Market Overview
Endoscopic Submucosal Dissection (ESD) is a technique developed in Japan that has since gained global traction due to its effectiveness in treating early-stage cancers while preserving organ integrity. Unlike traditional surgical procedures, ESD allows for the complete removal of large and flat gastrointestinal lesions in a single piece, minimizing recurrence and the need for invasive surgery.
As clinical guidelines evolve to favor earlier and less invasive cancer interventions, the ESD market is benefiting from:
- Increased screening programs for early gastrointestinal cancer,
- Growing preference for minimally invasive surgery across all age groups,
- Technological advancements in imaging and endoscopic tool design, and
- Improved post-procedural outcomes with reduced hospital stays.
Adoption is also expanding beyond large tertiary care centers to regional hospitals, driven by enhanced physician training and access to international clinical protocols.
Market Trends: Country-Wise Analysis
Japan
Japan is the birthplace of ESD and continues to lead globally in procedural volume and clinical innovation. The country has established ESD as a first-line treatment for early gastric and esophageal cancers. High physician expertise, national screening programs, and supportive reimbursement structures have created a mature, standardized environment for ESD practice.
Japan also continues to evolve ESD techniques through research and robotic endoscopy innovations, making it a benchmark for global market development. Advanced training centers and international fellowships hosted in Japan are further enabling global dissemination of expertise in therapeutic endoscopy.
South Korea
South Korea has rapidly become a stronghold for ESD adoption due to its healthcare infrastructure and emphasis on early cancer detection. National programs promoting screening for gastric and colorectal cancer have increased the pool of eligible patients for ESD procedures.
Hospitals in major cities like Seoul are equipped with cutting-edge endoscopic systems, and many physicians receive training in Japan. South Korea is also active in publishing data supporting ESD efficacy, contributing to growing regional confidence in advanced endoscopic techniques.
The rise in medical tourism for GI procedures in South Korea is another factor that supports market growth.
China
China's ESD market is in a phase of robust expansion. Driven by increasing cancer prevalence and a government-backed push toward minimally invasive medical technology, the country is rapidly upgrading its GI endoscopy capabilities. Large urban hospitals have already adopted ESD for early-stage gastric and esophageal tumors, particularly in the eastern provinces.
Though adoption remains lower in rural areas due to training and infrastructure gaps, ongoing investments in physician education and hospital modernization are expected to bridge this divide. China's massive population and rising cancer screening initiatives make it a key long-term market for ESD devices and techniques.
United States
The U.S. market for ESD is still emerging but gaining momentum. Historically reliant on Endoscopic Mucosal Resection (EMR), U.S. gastroenterologists are increasingly adopting ESD for lesions unsuitable for EMR or those requiring en bloc resection. Uptake is strongest in academic medical centers and GI specialty hospitals.
Barriers to wider adoption include longer procedural times, steep learning curves, and reimbursement limitations. However, as demand for minimally invasive surgery grows and more endoscopists complete ESD training programs, wider adoption is expected.
Additionally, growing awareness of early gastrointestinal cancer screening and new procedural guidelines from GI societies are creating tailwinds for the ESD market in the U.S.
E๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐: https://www.polarismarketresearch.com/industry-analysis/endoscopic-submucosal-dissection-market
Germany
Germany is a key driver of ESD adoption in Europe, owing to its strong endoscopy infrastructure and emphasis on clinical innovation. German hospitals are actively integrating ESD into gastroenterology and surgical departments, especially for early gastric, esophageal, and colorectal cancers.
The country benefits from national cancer screening initiatives and a healthcare model that facilitates technology integration. As patient demand for organ-sparing procedures rises, ESD is being used more frequently as a primary treatment option, especially for lesions with high risk of progression.
Germany also plays a critical role in clinical research and medical device evaluation in Europe, making it a focal point for companies and regulators working on ESD tools.
France
France has shown steady growth in the ESD market, propelled by investments in therapeutic endoscopy programs and colorectal cancer screening initiatives. ESD is increasingly being performed in larger public and university hospitals.
Barriers such as training availability and regional procedural disparities are gradually being addressed through national workshops and cross-border collaborations with neighboring countries. As France moves to enhance cancer outcomes with organ-preserving techniques, ESD is likely to gain broader institutional support.
India
India represents a growing market for ESD, albeit still in its early stages. With rising incidence of gastrointestinal cancers and increasing investment in healthcare infrastructure, tertiary hospitals in urban centers are starting to adopt ESD for early tumor removal.
However, lack of training and access to high-end endoscopic systems remain major barriers in smaller cities and rural areas. India is expected to show significant growth potential over the next decade as more gastroenterologists undergo international ESD training and healthcare reforms improve access to specialized care.
Brazil
In Latin America, Brazil is emerging as a key ESD market. Although the procedure is currently limited to select hospitals in major cities like São Paulo and Rio de Janeiro, increasing awareness about minimally invasive surgery and early cancer detection is driving interest in expanding its availability.
Brazil's rising middle class and improvements in insurance coverage for advanced procedures are supporting gradual market growth. Ongoing physician education and public-private partnerships could accelerate ESD adoption in the coming years.
United Kingdom
In the UK, ESD is being used selectively in centers of excellence, with broader adoption expected as clinical training and reimbursement pathways become more established. NHS initiatives promoting early cancer detection are likely to increase patient eligibility for ESD, particularly in the colorectal segment.
Challenges such as cost constraints and endoscopist availability are currently limiting widespread implementation. Nevertheless, as demand for organ-sparing therapies grows, ESD is positioned to become a key part of the UK's minimally invasive therapeutic toolkit.
Conclusion
The global Endoscopic Submucosal Dissection (ESD) market is entering a pivotal growth phase as healthcare systems across the world shift toward minimally invasive surgery, early intervention, and organ preservation. Countries like Japan and South Korea are setting clinical and operational benchmarks, while emerging economies such as China, India, and Brazil are scaling up infrastructure and training to meet demand.
The increased focus on detecting early gastrointestinal cancers, combined with rising patient awareness and procedural success rates, is driving a shift in treatment paradigms from surgical to endoscopic.
While challenges remain in the form of technical complexity, cost, and training limitations, the global trend toward advanced endoscopic techniques is undeniable. As this specialized field continues to evolve, the ESD market is expected to play a critical role in shaping the future of therapeutic endoscopy worldwide.
More Trending Latest Reports By Polaris Market Research:
Maritime Surveillance and Intervention Market
Citronella Oil Market: Harnessing the Power of Nature for a Refreshing Lifestyle
Photogrammetry Software Market